The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Hüseyin Ince
Showing 1-20 of 20 articles
A multicentre, randomised controlled clinical study of drug-coated balloons for the treatment of coronary in-stent restenosis
Hamm C,
Dörr O,
Woehrle J,
Krackhardt F,
Ince H,
Zeus T,
Berland J,
Piot C,
Roubille F,
Schult I,
Allocco D,
Nef H
July 17, 2020 | 10.4244/EIJ-D-19-00051
Lessons learned from the MitraSwiss registry
Ince H,
D’Ancona G
June 12, 2020 | 10.4244/EIJV16I2A14
Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial
Haude M,
Ince H,
Toelg R,
Lemos P,
von Birgelen C,
Christiansen E,
Wijns W,
Neumann F,
Eeckhout E,
Garcia-Garcia H,
Waksman R
February 7, 2020 | 10.4244/EIJ-D-18-01000
Diabetes and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: a pre-specified analysis from the randomised TROPICAL-ACS trial
Hein R,
Gross L,
Aradi D,
Rieber J,
Hadamitzky M,
Merkely B,
Huczek Z,
Ince H,
Hummel A,
Baylacher M,
Massberg S,
Trenk D,
Sibbing D
August 9, 2019 | 10.4244/EIJ-D-18-01077
MITRA-HR: the French correction vs the MitraClip. The race has started
D’Ancona G,
Ince H
July 19, 2019 | 10.4244/EIJV15I4A58
Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study
Bergmann M,
Ince H,
Kische S,
Schmitz T,
Meincke F,
Schmidt B,
Foley DP,
Betts TR,
Grygier M,
Protopopov A,
Stein KM,
Boersma L
April 20, 2018 | 10.4244/EIJ-D-17-00672
Mitral valve: repair/clips/cinching/chordae
Vahanian A,
Urena M,
Ince H,
Nickenig G
September 24, 2017 | 10.4244/EIJ-D-17-00505
Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registry
Bergmann M,
Betts TR,
Sievert H,
Schmidt B,
Pokushalov E,
Kische S,
Schmitz T,
Meincke F,
Stein KM,
Boersma L,
Ince H
September 20, 2017 | 10.4244/EIJ-D-17-00042
Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III
Haude M,
Ince H,
Kische S,
Abizaid A,
Toelg R,
Lemos P,
Van Mieghem N,
Verheye S,
von Birgelen C,
Christiansen E,
Wijns W,
Garcia-Garcia H,
Waksman R
July 20, 2017 | 10.4244/EIJ-D-17-00254
Combined mitro-aortic pathology: impact of previous aortic valve replacement upon outcomes of MitraClip therapy (from the German transcatheter mitral valve interventions registry)
D’Ancona G,
Kische S,
Senges J,
Ouarrak T,
Puls M,
Bekeredjian R,
Sievert H,
Safak E,
Ortak J,
Oener A,
Schillinger W,
Ince H
July 20, 2017 | 10.4244/EIJ-D-17-00222
A multicentre European registry to evaluate the Direct Flow Medical transcatheter aortic valve system for the treatment of patients with severe aortic stenosis
Naber C,
Pyxaras S,
Ince H,
Frambach P,
Colombo A,
Butter C,
Gatto F,
Hink U,
Nickenig G,
Bruschi G,
Brueren G,
Tchétché D,
den Heijer P,
Schillinger W,
Scholtz S,
Van der Heyden J,
Lefèvre T,
Gilard M,
Kuck K,
Schofer J,
Divchev D,
Baumgartner H,
Asch FM,
Wagner M,
Latib A,
De Marco F,
Kische S
December 9, 2016 | 10.4244/EIJ-D-15-00511
The MitraClip system: strategies for optimal patient selection and optimised results
Grasso C,
Ince H
September 18, 2016 | 10.4244/EIJV12SYA14
Real-world multicentre experience with the Direct Flow Medical® repositionable and retrievable transcatheter aortic valve implantation system for the treatment of high-risk patients with severe aortic stenosis
Naber C,
Pyxaras S,
Ince H,
Latib A,
Frambach P,
den Heijer P,
Wagner M,
Butter C,
Colombo A,
Kische S
February 12, 2016 | 10.4244/EIJV11I11A254
Percutaneous ventricular restoration (PVR) therapy using the Parachute device in 100 subjects with ischaemic dilated heart failure: one-year primary endpoint results of PARACHUTE III, a European trial
Thomas M,
Nienaber C,
Naber C,
Ince H,
Erglis A,
Vukcevic V,
Schäfer U,
Ferreira R,
Hardt S,
Verheye S,
Ribeiro V,
Sugeng L,
Tamburino C
October 20, 2015 | 10.4244/EIJV11I6A143
Treatment of pure aortic insufficiency after aortic stentless valve implantation: increasing safety with a transcatheter inflatable fully repositionable valve
Kische S,
D’Ancona G,
Ortak J,
Ince H
September 22, 2015 | 10.4244/EIJV11I5A117
Treatment of secondary mitral valve regurgitation: why we need combined and evolving percutaneous strategies to tackle this moving target
D’Ancona G,
Kische S,
Agma H,
Ince H
September 17, 2015 | 10.4244/EIJV11SWA13
How should I treat severe paravalvular leakage after TAVI?
Reinthaler M,
Empen K,
Busch M,
Konemann R,
Ince H,
Felix S
September 27, 2013 | 10.4244/EIJV9I5A104
Mitral valve repair using multiple MitraClips®: a dobutamine stress echocardiography evaluation
Paranskaya L,
D’Ancona G,
Bozdag-Turan I,
Kische S,
Akin I,
Turan G,
Ortak J,
Schuetz J,
Naber C,
Nienaber C,
Ince H
April 19, 2013 | 10.4244/EIJV8I12A210
Early and mid-term outcomes of percutaneous mitral valve repair with the MitraClip®: comparative analysis of different EuroSCORE strata
Paranskaya L,
D’Ancona G,
Bozdag-Turan I,
Akin I,
Kische S,
Turan G,
Divchev D,
Rehders T,
Schneider H,
Ortak J,
Naber C,
Nienaber C,
Ince H
September 28, 2012 | 10.4244/EIJV8I5A88
Myocardial repair by percutaneous cell transplantation of autologous skeletal myoblast as a stand alone procedure in post myocardial infarction chronic heart failure patients
Smits P,
Nienaber C,
Naber C,
Colombo A,
Ince H,
Carlino M,
Theuns D,
Biagini E,
Valgimigli M,
Onderwater E,
Steendijk P,
Peters N,
Goedhart D,
Serruys P
February 20, 2006
1
Latest news
AHEAD OF PRINT
Catheter-directed thrombolysis in intermediate-high risk acute pulmonary embolism
FREE ARTICLE - Josef Kroupa et al
May 27, 2022
EUROPCR LATE BREAKING
EuroPCR 2022 Late-breaking publications: watch the interviews with the authors!
May 23, 2022
NEW ISSUE
TAVI vs SAVR for bicuspid anatomies; PVR and TAVI; LAA thrombus trapping; crush techniques for bifurcation PCIs; stent elongation in POT and more
May 18, 2022
AHEAD OF PRINT
Delayed hospitalisation in the MITRA-FR trial
FREE ARTICLE - Guillaume Leurent et al
May 25, 2022
AHEAD OF PRINT
Complete cerebral protection during TAVI
FREE ARTICLE - Dariusz Jagielak et al
May 24, 2022
AHEAD OF PRINT
Outcomes of PCI for stent thrombosis
FREE ARTICLE - Mohamed O. Mohamed et al
May 24, 2022
EUROPCR LATE BREAKING
Changes in voice patterns for monitoring heart failure deterioration
FREE ARTICLE - Chaim Lotan et al
May 24, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke